Lexicon Pharmaceuticals Correlations
LXRX Stock | USD 0.36 0.01 3.86% |
The current 90-days correlation between Lexicon Pharmaceuticals and Seres Therapeutics is 0.16 (i.e., Average diversification). The correlation of Lexicon Pharmaceuticals is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak. If the correlation is 0, the equities are not correlated; they are entirely random.
Lexicon Pharmaceuticals Correlation With Market
Weak diversification
The correlation between Lexicon Pharmaceuticals and DJI is 0.37 (i.e., Weak diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Lexicon Pharmaceuticals and DJI in the same portfolio, assuming nothing else is changed.
Lexicon |
Moving together with Lexicon Stock
0.74 | CDIOW | Cardio Diagnostics | PairCorr |
0.7 | SCLX | Scilex Holding | PairCorr |
0.8 | ASMB | Assembly Biosciences Earnings Call Tomorrow | PairCorr |
0.76 | CMND | Clearmind Medicine Common | PairCorr |
0.62 | BA | Boeing | PairCorr |
0.75 | CAT | Caterpillar | PairCorr |
0.77 | HD | Home Depot | PairCorr |
0.76 | DIS | Walt Disney | PairCorr |
0.81 | MSFT | Microsoft Aggressive Push | PairCorr |
Moving against Lexicon Stock
0.61 | LUCD | Lucid Diagnostics | PairCorr |
0.58 | WM | Waste Management | PairCorr |
0.5 | PG | Procter Gamble | PairCorr |
0.31 | GE | GE Aerospace | PairCorr |
0.75 | JNJ | Johnson Johnson | PairCorr |
0.68 | T | ATT Inc Aggressive Push | PairCorr |
0.48 | XOM | Exxon Mobil Corp Earnings Call This Week | PairCorr |
0.43 | IBM | International Business | PairCorr |
0.42 | CVX | Chevron Corp | PairCorr |
0.35 | INTC | Intel Sell-off Trend | PairCorr |
0.35 | MMM | 3M Company | PairCorr |
Related Correlations Analysis
Click cells to compare fundamentals | Check Volatility | Backtest Portfolio |
Correlation Matchups
Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between Lexicon Stock performing well and Lexicon Pharmaceuticals Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Lexicon Pharmaceuticals' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
---|---|---|---|---|---|---|---|---|---|---|
BLRX | 5.24 | (1.00) | 0.00 | (1.70) | 0.00 | 9.73 | 60.21 | |||
ARDX | 3.24 | 0.11 | 0.02 | 0.04 | 4.42 | 8.32 | 27.51 | |||
MCRB | 3.45 | (0.14) | 0.00 | (0.09) | 0.00 | 7.81 | 35.32 | |||
IBRX | 4.28 | 0.06 | 0.03 | (0.14) | 4.70 | 9.81 | 40.57 | |||
EFTR | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
XFOR | 6.28 | (0.68) | 0.00 | (2.46) | 0.00 | 10.87 | 68.45 | |||
ELEV | 5.10 | (0.79) | 0.00 | (0.61) | 0.00 | 8.33 | 68.94 | |||
MREO | 2.63 | (0.41) | 0.00 | (0.56) | 0.00 | 6.16 | 20.77 | |||
HEPA | 9.83 | (3.90) | 0.00 | (7.20) | 0.00 | 16.37 | 90.05 |
Lexicon Pharmaceuticals Corporate Management
Kenneth MD | Senior Assurance | Profile | |
Chas Schultz | Executive Advocacy | Profile | |
Robert MD | Consultant Director | Profile | |
Tom Garner | Senior Officer | Profile | |
Suma Gopinathan | Vice Development | Profile | |
Desiree Gendron | Vice Training | Profile |